Spironolactone in dermatology: uses in acne and beyond.

T N Searle, F Al-Niaimi, F R Ali

Review Clinical and experimental dermatology 2020 20 件の引用

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D32844462'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

研究タイプ: Review
対象集団: Female pattern hair loss patients

介入: Spironolactone in dermatology: uses in acne and beyond. None
比較対照: None
主要アウトカム: None
効果の方向: Negative
バイアスリスク: Unclear

Abstract

Spironolactone is a synthetic aldosterone receptor antagonist, with a role off-label in various dermatological conditions. Its antiandrogenic properties make it suitable for diseases in which excess androgen production results in unwanted and psychologically distressing manifestations in susceptible females. Treatment with spironolactone aims to attenuate androgen-mediated conditions including acne, hidradenitis suppurativa, female pattern hair loss and hirsutism. We discuss the emerging utility of spironolactone in dermatology, its potential adverse effects and considerations for monitoring.

要約

Treatment with spironolactone aims to attenuate androgen‐mediated conditions including acne, hidradenitis suppurativa, female pattern hair loss and hirsutism.

Used In Evidence Reviews

A スピロノラクトン：女性型脱毛症

Spironolactone in dermatology: uses in acne and beyond.

Embed This Widget

Study Design

Abstract

要約

Used In Evidence Reviews

Similar Papers

Evaluation and treatment of male and female pattern hair loss.

Treatment of female pattern hair loss with oral antiandrogens.

Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.

Hair regrowth. Therapeutic agents.

Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.